在印度、巴西和美国强劲增长的推动下, Torrent Pharma的净利润年同比增长了26%, Torrent Pharma's net profit rose 26% year-on-year to ₹635 crore in Q3FY26, driven by strong growth in India, Brazil, and the U.S.

Torrent Pharmaceuticals在2026财年第三季度净利润同比增长26%，达到63.5亿卢比，收入增长17.6%，达到3303亿卢比，这得益于印度、巴西和美国的强劲表现。印度和巴西的收入分别增长14%和27%，超过了本地市场的增长，而美国业务增长了19%。 Torrent Pharmaceuticals posted a 26% year-on-year increase in net profit to ₹635 crore for Q3FY26, with revenue rising 17.6% to ₹3,303 crore, driven by strong performance in India, Brazil, and the U.S. India and Brazil saw revenue growth of 14% and 27% respectively, outpacing local market growth, while the U.S. business grew 19%. 德国收入增长了8%,但由于供应问题,以固定货币计算的收入下降了。 Germany revenue rose 8% but declined in constant currency due to supply issues. 该公司宣布在2026年3月支付每股29新西兰元的临时红利,其股票关闭额几乎未变,为4 074 005新西兰元。 The company declared an interim dividend of ₹29 per share, to be paid in March 2026, and its stock closed nearly unchanged at ₹4,074.05.